Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment
QFR102385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
3,235.00
Year-over-Year Change
3.79%
Date Range
10/1/2000 - 1/1/2025
Summary
This economic indicator tracks depreciation, depletion, and amortization expenses for U.S. pharmaceutical and medicine corporations' property, plant, and equipment. It provides critical insights into capital investment, asset management, and long-term financial strategies within this key industry sector.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
The trend represents the systematic allocation of asset costs over their useful economic life for pharmaceutical companies. Economists use this metric to assess capital expenditure patterns, investment efficiency, and potential technological reinvestment in the pharmaceutical sector.
Methodology
Data is collected through quarterly financial reports submitted by pharmaceutical corporations, aggregating depreciation and amortization expenses across the industry.
Historical Context
This indicator helps policymakers and investors understand capital investment trends, technological innovation, and financial health in the pharmaceutical manufacturing industry.
Key Facts
- Tracks systematic allocation of asset costs in pharmaceutical manufacturing
- Provides insights into long-term capital investment strategies
- Reflects technological reinvestment and asset management efficiency
FAQs
Q: What does this economic indicator measure?
A: It measures depreciation, depletion, and amortization expenses for pharmaceutical companies' property, plant, and equipment, reflecting their capital investment strategies.
Q: Why is this trend important for investors?
A: It helps investors understand how pharmaceutical companies manage and invest in their physical assets, indicating potential future growth and technological innovation.
Q: How often is this data updated?
A: The data is typically updated quarterly, providing a consistent snapshot of the pharmaceutical industry's capital expenditure trends.
Q: What can this trend reveal about industry health?
A: It can indicate the sector's investment in new technologies, equipment upgrades, and overall financial resilience.
Q: Are there limitations to this economic indicator?
A: While valuable, the indicator only represents accounting expenses and should be analyzed alongside other financial metrics for a comprehensive understanding.
Related News
Gen Z In the U.S. Shifts From Spending To Saving Habits
How Gen Z's Shift from Spending to Saving is Impacting the US Economy Recent trends indicate a significant shift in the spending habits of Gen Z, w...
U.S. Treasury Yields Decline After Inflation Data Meet Expectations
US Treasury Yields Drop as Inflation Data Meets Expectations US Treasury yields have seen a noticeable decline recently, as the latest inflation da...
S&P 500 Rises With Optimistic U.S. Inflation Report
S&P 500 Soars: Positive U.S. Inflation Developments The S&P 500, a primary stock index that tracks the performance of 500 major U.S. companies, has...
U.S. Stock Market Rises Amid PCE Inflation Report Analysis
U.S. Stock Market Climbs Amidst Insights from PCE Inflation Report Investors in the U.S. stock market are focusing on the most recent PCE Inflation...
U.S. GDP Growth to Slow Due to Tariffs and Immigration Policies
How Tariffs and Immigration Policies Influence U.S. GDP Growth in 2025 The U.S. GDP is a fundamental gauge of the country's economic health. Recent...
U.S. Stock Market Futures Rise On Inflation and Tariff News
US Stock Market Futures Rise Amid Inflation Data and Tariff News US stock market futures are on the rise, driven by significant updates in inflatio...
Related Trends
Quarterly Financial Report: U.S. Corporations: Motor Vehicles and Parts: Total Cash, U.S. Government and Other Securities
QFRTCASH2376USNO
Quarterly Financial Report: U.S. Corporations: All Wholesale Trade: Net Sales, Receipts, and Operating Revenues
QFR101WHSUSNO
Quarterly Financial Report: U.S. Corporations: Management and Technical Consulting Services: Land and Mineral Rights
QFR217546USNO
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Current Portion of Long-Term Debt, Due in 1 Year or Less: Loans from Banks
QFR310545USNO
Quarterly Financial Report: U.S. Corporations: All Professional and Technical Services, Except Legal Services: Total Assets
QFR223PTSUSNO
Quarterly Financial Report: U.S. Corporations: Motion Picture and Sound Recording Industries: Property, Plant, and Equipment
QFR216512USNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Depreciation, Depletion, and Amortization of Property, Plant, and Equipment [QFR102385USNO], retrieved from FRED.
Last Checked: 8/1/2025